Blog - Cancer Care Italy


+1 347 964 0123

+39 06 9934 1213

info@cancercare.it
Go to content
Hadrontherapy is an advanced and evolved form of radiotherapy, developed to treat tumours which are inoperable and resistant to traditional radiation treatments...
90% of successful cancer treatment is done through damaging, invasive procedures... CNAO is changing this. The Italian Centro Nazionale di Adroterapia Oncologica (CNAO), is changing...
Chordoma and chondrosarcoma have traditionally been considered an indication for proton therapy. Their characteristic anatomical location of onset, the base of the skull and spine, the difficulties of...
Our Consultant says why you should not confuse common Cyclotron with advanced ...
CNAO’s ‘High Technology’ components consist of a set of accelerators and transport lines of particle beams. The beams are generated by sources that produce carbon ions and protons. The most important accelerator machine is the Synchrotron. The synchrotron at CNAO is a prototype resulting from the research in high energy physics made possible through the collaboration of the Istituto Nazionale di Fisica Nucleare (INFN), CERN (Switzerland), GSI (Germany), LPSC (France) and of the University of Pavia University (Italy). It is based mostly on Italian technology...
Rapid technological progress in recent years has led to an evolution in all areas of medicine and has significantly influenced radiation oncology. Today, a new frontier in radiation therapy is represented by the hadrontherapy, which is the use of protons and atomic nuclei (ions) called hadrons (from the Greek hadrós, strong) that are subjected to a strong nuclear force...
Copyright © 2018 - Cancer Care Italy
Venitaly Scarl P.IVA IT03725740249 | Via Degli Uffici del Vicario, 33 - 00186 ROMA - Italy
Via P. Mascagni, 20 - 36100 VICENZA | Home to U.S. Army Base EDERLE
Tel USA : +1 347 964 0123 | Tel Italy: +39 06 9934 1213 | FAX: +39 06 6220 2062
Email: info@cancercare.it | Privacy Policy
PARTNER
Back to content